Topics

Rubius Exec Dowden Departs for Entrada Chief Operating Officer Post

18:16 EST 7 Nov 2019 | Xconomy

Entrada Therapeutics has appointed Nathan Dowden to serve as its chief operating officer. He joins Boston-based Entrada from Rubius Therapeutics, where he was senior vice president of strategy and corporate development. Entrada is developing drugs that that use cell-penetrating peptides to bring a therapy into a cell. Last year, the biotech raised $59 million in […]

Original Article: Rubius Exec Dowden Departs for Entrada Chief Operating Officer Post

NEXT ARTICLE

More From BioPortfolio on "Rubius Exec Dowden Departs for Entrada Chief Operating Officer Post"

Quick Search

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...